Artykuły w czasopismach na temat „Allo-reactivity”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Allo-reactivity”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Huisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, J. H. Frederik Falkenburg i Inge Jedema. "The Scope of Allo-HLA Cross-Reactivity By (Third Party) Virus Specific T Cells Is Surprisingly Affected By HLA Restriction Rather Than Virus Specificity". Blood 132, Supplement 1 (29.11.2018): 2048. http://dx.doi.org/10.1182/blood-2018-99-116028.
Pełny tekst źródłaWebb, S. R., J. H. Li, I. MacNeil, P. Marrack, J. Sprent i D. B. Wilson. "T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes." Journal of Experimental Medicine 161, nr 1 (1.01.1985): 269–74. http://dx.doi.org/10.1084/jem.161.1.269.
Pełny tekst źródłaAmir, Avital L., Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate S. Hagedoorn, Renate de Boer, Menno A. W. G. van der Hoorn i in. "Allo-HLA reactivity of virus-specific memory T cells is common". Blood 115, nr 15 (15.04.2010): 3146–57. http://dx.doi.org/10.1182/blood-2009-07-234906.
Pełny tekst źródłaHuisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, Fred Falkenburg i Inge Jedema. "Off-Target HLA Cross-Reactivity By (Third Party) Virus-Specific T Cells Is Surprisingly Affected By HLA Restriction and HLA Background but Not By Virus Specificity". Blood 134, Supplement_1 (13.11.2019): 4440. http://dx.doi.org/10.1182/blood-2019-124785.
Pełny tekst źródłaHasenkamp, Justin, Andrea Borgerding, Bjoern Chapuy, Gerald Wulf, Inga Missal, Wolfram Jung, Lorenz Truemper i Bertram Glass. "Allo-Reactive NK Cells after HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation." Blood 108, nr 11 (16.11.2006): 2904. http://dx.doi.org/10.1182/blood.v108.11.2904.2904.
Pełny tekst źródłaWebb, S. R., A. Okamoto i J. Sprent. "Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants." Journal of Immunology 141, nr 6 (15.09.1988): 1828–34. http://dx.doi.org/10.4049/jimmunol.141.6.1828.
Pełny tekst źródłaElkon, Keith B., i Dalit Ash Any. "Autoimmunity Versus Allo- and Xeno-Reactivity in SCID Mice". International Reviews of Immunology 11, nr 4 (styczeń 1994): 283–93. http://dx.doi.org/10.3109/08830189409051175.
Pełny tekst źródłaLaghmouchi, Aicha, Conny Hoogstraten, Peter Van Balen, Rick van de Water, Marian van de Meent, J. H. Frederik Falkenburg i Inge Jedema. "The Allo-HLA-DP Restricted T Cell Repertoire Contains a Variety of Tissue-Restricted Specificities with Therapeutic Value". Blood 128, nr 22 (2.12.2016): 3356. http://dx.doi.org/10.1182/blood.v128.22.3356.3356.
Pełny tekst źródłaNoonan, Kimberly, Leo Luznik i Ivan M. Borrello. "Enrichment of Allogeneic Tumor Antigen-Specific T Cells From Bone Marrow (BM) of Patients Treated with High-Dose Post-Transplant Cyclophoshamide (Cy) – A Novel Approach to Adoptive Immunotherapy". Blood 118, nr 21 (18.11.2011): 647. http://dx.doi.org/10.1182/blood.v118.21.647.647.
Pełny tekst źródłaD’Orsogna, Lloyd, Heleen van den Heuvel, Cees van Kooten, Sebastiaan Heidt i Frans H. J. Claas. "Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms". Immunogenetics 69, nr 8-9 (17.07.2017): 631–41. http://dx.doi.org/10.1007/s00251-017-0989-3.
Pełny tekst źródłaByun, Nari, Hyun-Je Kim, Il-Hee Yoon i Oh-Sang Kwon. "Cross reactivity of allo and xenoimmune response in transplantation (TRAN2P.964)". Journal of Immunology 194, nr 1_Supplement (1.05.2015): 209.4. http://dx.doi.org/10.4049/jimmunol.194.supp.209.4.
Pełny tekst źródłaHueso, Thomas, Leonardo Magro, Marie Jonquel-chevalier Curt, Ibrahim Yakoub-Agha i David Seguy. "Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD". Blood 128, nr 22 (2.12.2016): 4592. http://dx.doi.org/10.1182/blood.v128.22.4592.4592.
Pełny tekst źródłaBurkhardt, Ute E., Ursula Hainz, Kristen E. Stevenson, Di Wu, Vincent T. Ho, Natalie R. Goldstein, Mildred Pasek i in. "Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL)". Blood 120, nr 21 (16.11.2012): 1892. http://dx.doi.org/10.1182/blood.v120.21.1892.1892.
Pełny tekst źródłaten Berge, Ineke, Kirstin Heutinck, Unsal Yapici, Geurt Stokman, Sandrine Florquin, Cees van Kooten, G. Garcia-Romo i in. "The interplay between antiviral immunity and allo-immune reactivity after renal transplantation". Transplant Immunology 31, nr 4 (październik 2014): 191–94. http://dx.doi.org/10.1016/j.trim.2014.09.004.
Pełny tekst źródłaKarahan, Gonca E., Frans H. J. Claas i Sebastiaan Heidt. "Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ Transplantation". Viruses 13, nr 12 (24.11.2021): 2359. http://dx.doi.org/10.3390/v13122359.
Pełny tekst źródłaBondanza, Attilio, Veronica Valtolina, Zulma Magnani, Maurilio Ponzoni, Katharina Fleischhauer, Mark Bonyhadi, Catia Traversari i in. "Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes". Blood 107, nr 5 (1.03.2006): 1828–36. http://dx.doi.org/10.1182/blood-2005-09-3716.
Pełny tekst źródłaAmir, Avital L., Dirk M. van der Steen, Renate S. Hagedoorn, Michel G. D. Kester, Cornelis A. M. van Bergen, Jan W. Drijfhout, Arnoud H. de Ru, J. H. Frederik Falkenburg, Peter A. van Veelen i Mirjam H. M. Heemskerk. "Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific". Blood 118, nr 26 (22.12.2011): 6733–42. http://dx.doi.org/10.1182/blood-2011-05-354787.
Pełny tekst źródłaKuball, Jürgen, Wouter Scheper, Suzanne van Dorp, Sabina Kersting, Floor Pietersma, Samantha Hol, Victoria Marcu-Malina, Sabine Becke, Bodo Plachter i Debbie van Baarle. "Multipotent Vδ2-negative γδT-cells after CMV-reactivation in allogeneic stem cell transplantation (162.36)". Journal of Immunology 188, nr 1_Supplement (1.05.2012): 162.36. http://dx.doi.org/10.4049/jimmunol.188.supp.162.36.
Pełny tekst źródłaBondanza, Attilio, Veronica Valtolina, Zulma Magnani, Shin Kaneko, Maurilio Ponzoni, Francesca Sanvito, Mark Bonyhadi i in. "Suicide Gene Therapy of Graft-Versus-Host Disease Induced by Central Memory Human T Lymphocytes." Blood 106, nr 11 (16.11.2005): 3096. http://dx.doi.org/10.1182/blood.v106.11.3096.3096.
Pełny tekst źródłaKarmaus, W., i V. Gangur. "Does allo-immune reactivity play a role in the prenatal programming of childhood allergy?" Clinical Experimental Allergy 35, nr 4 (kwiecień 2005): 405–7. http://dx.doi.org/10.1111/j.1365-2222.2005.02218.x.
Pełny tekst źródłaMarkiewicz, Miroslaw, Urszula Siekiera, Tomasz Kruzel, Monika Dzierzak-Mietla, Patrycja Zielinska i Slawomira Kyrcz-Krzemien. "DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors." Blood 116, nr 21 (19.11.2010): 4575. http://dx.doi.org/10.1182/blood.v116.21.4575.4575.
Pełny tekst źródłaUdaka, K., K. H. Wiesmüller, S. Kienle, G. Jung i P. Walden. "Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone." Journal of Immunology 157, nr 2 (15.07.1996): 670–78. http://dx.doi.org/10.4049/jimmunol.157.2.670.
Pełny tekst źródłaKlobuch, Sebastian, Kathrin Hammon, Sarah Vatter-Leising, Elisabeth Neidlinger, Michael Zwerger, Annika Wandel, Laura Maria Neuber i in. "HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation". Cells 9, nr 5 (20.05.2020): 1264. http://dx.doi.org/10.3390/cells9051264.
Pełny tekst źródłaAdam, Jacqueline, Natascha Wuillemin, Stephan Watkins, Heidi Jamin, Klara K. Eriksson, Peter Villiger, Stefano Fontana, Werner J. Pichler i Daniel Yerly. "Abacavir Induced T Cell Reactivity from Drug Naïve Individuals Shares Features of Allo-Immune Responses". PLoS ONE 9, nr 4 (21.04.2014): e95339. http://dx.doi.org/10.1371/journal.pone.0095339.
Pełny tekst źródłaPearson, Todd, Marie King, Leonard Shultz, Jean Leif, Dale Greiner, John Mordes, Aldo Rossini i in. "Development of Latest-generation HU-PBMC-NOD/SCID Mice to Study Human Islet Allo-reactivity". Clinical Immunology 123 (2007): S69. http://dx.doi.org/10.1016/j.clim.2007.03.374.
Pełny tekst źródłaTawara, Isao, Kana Okamori, Naoyuki Katayama, Hiroshi Shiku i Hiroaki Ikeda. "Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation". Blood 128, nr 22 (2.12.2016): 2157. http://dx.doi.org/10.1182/blood.v128.22.2157.2157.
Pełny tekst źródłaJürgens, Birgit, Julia Raberger, Dietmar Fuchs i Andreas Heitger. "Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation". International Journal of Tryptophan Research 3 (styczeń 2010): IJTR.S4076. http://dx.doi.org/10.4137/ijtr.s4076.
Pełny tekst źródłavan Bergen, Cornelis A. M., Simone A. P. Van Luxemburg-Heijs, Matthijs Eefting, Maria W. Honders, Inge Jedema, Constantijn J. M. Halkes, Marieke Griffioen i J. H. Frederik Falkenburg. "Graft Versus Leukemia Separates From Graft Versus Host Disease By Magnitude and Avidity Of The Allo-Reactive T Cell Response After Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion". Blood 122, nr 21 (15.11.2013): 2014. http://dx.doi.org/10.1182/blood.v122.21.2014.2014.
Pełny tekst źródłaMielke, Stephan, Raquel Nunes, Katayoun Rezvani, Vicki S. Fellowes, Yong Fan, Scott R. Solomon, Christian Scotto, Elizabeth J. Read i A. John Barrett. "High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs." Blood 108, nr 11 (16.11.2006): 721. http://dx.doi.org/10.1182/blood.v108.11.721.721.
Pełny tekst źródłaDavid, V., J. F. Bourge, P. Guglielmi, D. Mathieu-Mahul, L. Degos i A. Bensussan. "Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity." Journal of Immunology 138, nr 9 (1.05.1987): 2831–36. http://dx.doi.org/10.4049/jimmunol.138.9.2831.
Pełny tekst źródłaRowntree, Louise C., Thi H. O. Nguyen, Stephanie Gras, Tom C. Kotsimbos i Nicole A. Mifsud. "Deciphering the clinical relevance of allo-human leukocyte antigen cross-reactivity in mediating alloimmunity following transplantation". Current Opinion in Organ Transplantation 21, nr 1 (luty 2016): 29–39. http://dx.doi.org/10.1097/mot.0000000000000264.
Pełny tekst źródłaGamadia, Laila E., Ester B. Remmerswaal, Sugianto Surachno, Neubury M. Lardy, Pauline M. Wertheim-van Dillen, Ren?? A. W. van Lier i Ineke J. M. ten Berge. "CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES". Transplantation 77, nr 12 (czerwiec 2004): 1879–85. http://dx.doi.org/10.1097/01.tp.0000131158.81346.64.
Pełny tekst źródłaQureshi, Khalid M., Jou Lee, Michelle B. Paget, Clifford J. Bailey, S. John Curnow, Hilary E. Murray i Richard Downing. "Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity". Clinical Transplantation 29, nr 1 (5.12.2014): 90–98. http://dx.doi.org/10.1111/ctr.12488.
Pełny tekst źródłaMethe, Heiko, Adam Groothuis, Mohamed H. Sayegh i Elazer R. Edelman. "Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo‐ and xenogeneic models". FASEB Journal 21, nr 7 (30.01.2007): 1515–26. http://dx.doi.org/10.1096/fj.06-7051com.
Pełny tekst źródłaD’Orsogna, Lloyd J., Frans H. J. Claas, Mina John, Coral-Ann Almeida, Paula van Miert, Sonia Fernandez i Yvonne Zoet. "OR24 Allo-HLA reactivity by HIV-specific T-cells: A potential adjunct to HIV vaccine design?" Human Immunology 76 (październik 2015): 9. http://dx.doi.org/10.1016/j.humimm.2015.07.016.
Pełny tekst źródłaSommer, Cesar, Bijan Boldajipour, Julien Valton, Roman Galetto, Trevor Bentley, Janette Sutton, Yajin Ni i in. "ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma". Blood 132, Supplement 1 (29.11.2018): 591. http://dx.doi.org/10.1182/blood-2018-99-119227.
Pełny tekst źródłaCousens, Leslie P., i Pamela A. Davol. "Targeting Lymphoma with Bispecific Antibody-Armed T Cells and their Potential for use in an Allogeneic Setting (41.31)". Journal of Immunology 182, nr 1_Supplement (1.04.2009): 41.31. http://dx.doi.org/10.4049/jimmunol.182.supp.41.31.
Pełny tekst źródłaMorse, H. C., R. A. Yetter, C. S. Via, R. R. Hardy, A. Cerny, K. Hayakawa, A. W. Hugin, M. W. Miller, K. L. Holmes i G. M. Shearer. "Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome." Journal of Immunology 143, nr 3 (1.08.1989): 844–50. http://dx.doi.org/10.4049/jimmunol.143.3.844.
Pełny tekst źródłaRaghunathan, R., T. M. Mundy, J. Faust i S. Misra. "Allogeneic leukocyte and germ cell-induced murine immunodeficiency." Journal of Immunology 135, nr 4 (1.10.1985): 2429–31. http://dx.doi.org/10.4049/jimmunol.135.4.2429.
Pełny tekst źródłaYao, Xin, Fenlu Zhu, Huiqing Xu i Carolyn A. Keever-Taylor. "Allo-Reactive Potential of Multi-Virus Specific Cytotoxic T Cell Lines Recognizing Adenovirus Hexon, Cytomegalovirus pp65 and Epstein Barr Virus." Blood 114, nr 22 (20.11.2009): 5121. http://dx.doi.org/10.1182/blood.v114.22.5121.5121.
Pełny tekst źródłaCastro, Januario E., Juan S. Barajas-Gamboa, Julio A. Diaz-Perez, Lina M. Ariza-Serrano, Sue Corringham, Thomas J. Kipps i Edward D. Ball. "Improved Outcome in Unrelated Donor Recipients After Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Advanced Relapse / Refractory Chronic Lymphocytic Leukemia". Blood 118, nr 21 (18.11.2011): 4474. http://dx.doi.org/10.1182/blood.v118.21.4474.4474.
Pełny tekst źródłaMelenhorst, J. Joseph, Ann M. Leen, Catherine M. Bollard, Máire F. Quigley, David A. Price, Cliona M. Rooney, Malcolm K. Brenner, A. John Barrett i Helen E. Heslop. "Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects". Blood 116, nr 22 (25.11.2010): 4700–4702. http://dx.doi.org/10.1182/blood-2010-06-289991.
Pełny tekst źródłaSommer, Cesar, Hsin-Yuan Cheng, Yik Andy Yeung, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton i in. "Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia". Blood 134, Supplement_1 (13.11.2019): 3921. http://dx.doi.org/10.1182/blood-2019-129025.
Pełny tekst źródłaBlomberg, B. B., S. Hussini, H. Fainman, J. M. Mathew, A. Hernandez, M. Carreno, H. J. Hnatyszyn i in. "Retroviral transduction of an allogeneic class II gene into human bone marrow down regulates allo-immune reactivity". Human Immunology 64, nr 10 (październik 2003): S128. http://dx.doi.org/10.1016/j.humimm.2003.08.240.
Pełny tekst źródłaAmir, Avital, Marieke Griffioen, Michel D. G. Kester, M. Willy Honders, Roelof Willemze, J. H. Frederik Falkenburg i Mirjam Heemskerk. "Allo-HLA Reactive CD8 T-Cells May Recognize Tissue Specific Peptides Explaining Tissue Restricted GVHD after HLA Mismatched SCT." Blood 110, nr 11 (16.11.2007): 72. http://dx.doi.org/10.1182/blood.v110.11.72.72.
Pełny tekst źródłaStevanovic, Sanja, Bart Nijmeijer, Marianke LJ Van Schie, Roelof Willemze, Marieke Griffioen i J. H. Frederik Falkenburg. "Human T Cells with Distinct Specificities Mediate Graft-Versus-Leukemia Reactivity and Xenogeneic Graft-Versus-Host Disease in a NOD/Scid Mouse Model for Human Acute Leukemia." Blood 114, nr 22 (20.11.2009): 1330. http://dx.doi.org/10.1182/blood.v114.22.1330.1330.
Pełny tekst źródłaFirer, Michael A., Sofi Yado, Luboshits Galia i Reuven Or. "A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease". Blood 132, Supplement 1 (29.11.2018): 3339. http://dx.doi.org/10.1182/blood-2018-99-110292.
Pełny tekst źródłaBurrack, Adam, Maki Nakayama, Laurie Landry, Marilyne Coulombe i Ronald Gill. "Autoimmunity as an endogenous source of heterologous alloimmunity (TRAN3P.868)". Journal of Immunology 192, nr 1_Supplement (1.05.2014): 202.7. http://dx.doi.org/10.4049/jimmunol.192.supp.202.7.
Pełny tekst źródłaPilunov, Artem, Dmitrii S. Romaniuk, Anton Shmelev, Savely Sheetikov, Anna N. Gabashvili, Alexandra Khmelevskaya, Dmitry Dianov i in. "Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells". Cancers 15, nr 5 (3.03.2023): 1592. http://dx.doi.org/10.3390/cancers15051592.
Pełny tekst źródłaStaba, Susan Lynn, Melissa Reese i Joanne Kurtzberg. "Immunophenotype and Analysis of Allo-Reactivity of Umbilical Cord Blood (UCB)-Derived T-Cells Following Ex-Vivo Expansion." Blood 104, nr 11 (16.11.2004): 403. http://dx.doi.org/10.1182/blood.v104.11.403.403.
Pełny tekst źródła